Bibliometric analysis of dendritic cell-based vaccines over the past 15 years
Zhi Long Yinghua Wu Liangchen Zhong Jiping Lu Bo Liu a Department of Neurosurgery,Xiangya Hospital,Central South University,Jiangxi,Chinab Hypothalamic-Pituitary Research Center,Xiangya Hospital,Central South University,Changsha,Chinac National Clinical Research Center for Geriatric Disorders,Xiangya Hospital,Central South University,Changsha,Chinad Orthopedics Department,921 Hospital,Joint Logistics Support Force People's Liberation Army of China,Changsha,China
DOI: https://doi.org/10.1080/21645515.2024.2392961
2024-08-22
Human Vaccines & Immunotherapeutics
Abstract:Dendritic cells, which are crucial for inducing T-cell responses, are pivotal in current immunotherapy strategies aiming to replenish depleted T cells within the tumor microenvironment to combat tumors. Consequently, dendritic cell vaccine-based cancer therapies have garnered significant attention. Through bibliometric analysis, we examined research trends in this field. We searched the Web of Science core database and identified 16,476 articles on dendritic cell-based vaccines published from January 1, 2009, to December 30, 2023. The United States leads in this research domain, with Emory University being a prominent collaborator. The Journal of Immunology is the primary publication outlet, and Banchereau, J emerges as the most influential author. Recent hot keywords include nanoparticle, delivery, cancer vaccine, and clinical trial, indicating that cancer immunotherapy research, especially dendritic cell-based vaccines, is poised to become a future trend and hotspot.
immunology,biotechnology & applied microbiology